baber/WOPTO huggingface dataset:
Patent CA-2272621-C (CA)
Title: Multi-kernel neural network concurrent learning, monitoring, and forecasting system
Inventor: JANNARONE ROBERT J
IPC: G06N3/00
Filed: 1997-11-19
Granted: 2006-07-04
Abstract: A multi-kernel neural network computing architecture configured to learn correlations among feature values (34, 38) as the network monitors and imputes measured input values (30) and also predicts future output values (46). This computing architecture, referred to as a concurrent-learning information processor (CIP 10), includes a multi-kernel neural network array (14) with the capability to learn and predict in real time. The CIP (10) also includes a manager (16) and an input-output transducer (12) that may be used for input-output refinement. These components allow the computing capacity of the multi-kernel array (14) to be re-assigned in response to measured performance or other factors. The output feature values (46) computed by the multi-kernel array (14) and processed by an output processor (44) of the transducer (12) are supplied to a response unit (18) that may be configured to perform a variety of monitoring, forecasting, and control operations in response to the computed output values. Important characteristics of the CIP (10), such as feature function specifications (35 and 49), connection specifications (42), learning weight schedules (55), and the like may be set by a technician through a graphical user interface (20). Refinement processes also allow the CIP (10) to be reconfiguredin accordance with user commands for application to different physical applications.
Patent CA-2273167-C (CA)
Inventor: WITTNER LUPU
IPC: H02J3/14
Filed: 1997-12-05
Granted: 2005-10-11
Abstract: Cette invention se rapporte à un appareil et à un procédé permettant de répartir uniformément une charge électrique dans un réseau de distribution d'énergie polyphasée. On mesure l'intensité du courant dans chaque phase d'entrée ( phi 1,  phi 2 et  phi 3) et dans chaque dérivation (1-5) au moyen de capteurs de courant (16, 18, 20, 42, 44, 46, 48 et 50) dont les sorties sont contrôlées par un processeur (12). Chaque dérivation est associée à un commutateur multipolaire (22, 24, 26, 28 et 30) et à un disjoncteur classique (32, 34, 36, 38, 40). Chaque commutateur (22, 24, 26, 28 et 30) peut connecter sa dérivation correspondante (1-5) à n'importe quelle phase d'entrée ( phi 1,  phi 2 et  phi 3), ou déconnecter cette dérivation (1-5) de toutes les phases ( phi 1,  phi 2 et  phi 3). Le processeur (12) contrôle périodiquement les courants circulant dans chaque phase d'entrée et, en fonction des conditions de charge des dérivations (1-5), reprogramme les commutateurs (22, 24 et 26) de façon à ce que les charges des dérivations (1-5) restent réparties uniformément sur les trois phases d'entrée ( phi 1,  phi 2 et  phi 3).
Patent CA-2283630-C (CA)
Inventor: ENRIGHT FREDERICK M
IPC: A61P35/00
Filed: 1998-03-27
Granted: 2011-08-30
Abstract: Amphipathic lytic peptides are ideally suited to use in a ligand/cytotoxin combination to specifically inhibit cells that are driven by or are dependent upon a specific ligand interaction; for example, to induce sterility or long-term contraception, or to attack tumor cells, or to selectively lyse virally-infected cells, or to attack lymphocytes responsible for autoimmune diseases. The peptides act directly on cell membranes, and need not be internalized. Administering a combination of gonadotropin-releasing hormone (GnRH) (or a GnRH agonist) and a membrane-active lytic peptide produces long-term contraception or sterilization in animals in vivo. Administering in vivo a combination of a ligand and a membrane-active lytic peptide kills cells with a receptor for the ligand. The compounds are relatively small, and are not antigenic. Lysis of gonadotropes has been observed to be very rapid (on the order of ten minutes). Lysis of tumor cells is rapid. The two components -the ligand and the lytic peptide- may optionally be administered as a fusion peptide, or they may be administered separately, with the ligand administered slightly before the lytic peptide, to activate cells with receptors for the ligand, and thereby make those cells susceptible to lysis by the lytic peptide. The compounds may be used in gene therapy to treat malignant or non-malignant tumors, and other diseases caused by clones or populations of "normal" host cells bearing specific receptors (such as lymphocytes), because genes encoding a lytic peptide or encoding a lytic peptide/peptide hormone fusion may readily be inserted into hematopoietic stem cells or myeloid precursor cells.
Patent CA-2293140-C (CA)
Inventor: TATE JOHN R
IPC: A63B57/35
Filed: 1999-12-24
Granted: 2004-05-11
Abstract: A golf ball marker or other small article that is attracted by the force of magnetism is carried in open display on a fabric article of clothing or other fabric accessory. The ferrous article remains in position on the clothing due to the force of magnetism. To produce this effect, a permanent magnet is secured in position on the fabric article, often in contact with a concealed side of a layer of fabric of which the fabric article is formed. A golf ball marker, golf divot repair tool, golf pencil with a ferrous band, or other article that is constructed of or which includes a ferrous material is placed into contact with an exposed layer of the fabric to which the permanent magnet is secured. The ball marker or other article is held by the force of magnetic attraction that typically acts through the fabric layer of material from the concealed side thereof to create a magnetic field on the visually exposed side of the fabric material. The ball marker or other material remains in position until purposefully dislodged by a force that opposes and overcomes the magnetic field created by the permanent magnetic. The permanent magnet may be incorporated into the crown, bill, or band of a hat or cap, a golf sun visor, or into the closure flap of a golfing glove, a golf towel, or the structure of a golf bag. The magnetic retention system may be sold as a unit for attachment to a layer of fabric. Such an embodiment may take the form of a tray formed of flexible plastic that defines a cavity that receives the magnet.
Patent CA-2302066-C (CA)
Inventor: GUILLOT EDMOND P
IPC: A47D7/00
Filed: 2000-03-23
Granted: 2006-07-18
Abstract: Concealed hardware for controlling the raising and lowering of the crib side, permits the construction of a crib which includes no projecting or exposed parts. The hardware comprises a channel member embedded within the end stiles of the crib side and an engaged coupling element fastened to the adjacent crib end. The channel member restricts movement of the crib side to vertical translation, and includes a latching chamber at the bottom which selectively traps or releases the coupling element when it is desired to secure the crib side in an elevated position.
Patent CA-2317568-C (CA)
Inventor: CHEN CHAO
IPC: A23L35/00
Filed: 1999-01-08
Granted: 2005-05-10
Abstract: Methods of preserving fresh vegetables with a vegetable preservative which extends the shelf life of fresh vegetables, particularly cut fresh vegetables, are provided. The vegetable preservative preserves the texture, flavor, appearance, crispness, and moisture of the fresh vegetables, particularly fresh cut vegetables. In the preferred embodiment, the method comprises the following steps: providing a preservative solution comprising: water, calcium ions; and preferably ascorbate ions, and, applying said vegetable preservative to the vegetable. The vegetable preservative solution contains preferably from about 0.075 % to a saturated solution, more preferably from about 0.2 % to about 20 %, even more preferably from about 0.5 % to about 10 %, even more preferably from about 0.5 % to about 8 % most preferably from about 0.6 % to about 5 %, by weight, calcium salt; and preferably from about 0 % to about 30 %, more preferably from about 0.1 % to about 30 %, even more preferably from about 0.5 % to about 15 %, most preferably from about 1.0 % to about 5 %, by weight, ascorbic acid or the stereo isomer of ascorbic acid, erythorbic acid.  The invention also relates to fresh vegetables preserved with the vegetable preservatives.
Patent CA-2318760-C (CA)
Title: Method for determining dna nucleotide sequence
Inventor: HAYASHIZAKI YOSHIHIDE
IPC: C12N15/09
Filed: 1999-01-22
Granted: 2010-08-10
Abstract: A method for determining the base sequence of a target DNA fragment which comprises amplifying the DNA fragment while forming a nucleic acid transcript by using an RNA polymerase with the use of the thus amplified DNA fragment as a template in the presence of a nucleic acid transcript terminator, and then analyzing the nucleic acid transcript thus obtained, wherein the amplification of the target DNA fragment and the formation of the transcript are effected isothermally. The amplification of the target DNA fragment and the formation of the transcript are effected at around ordinary temperature and the target DNA fragment can be amplified by the strand replacement/amplification method. According to this novel method, a DNA can be sequenced by effecting the amplification of the target DNA fragment and the formation of the nucleic acid transcript at the same time without resort to any thermostable RNA polymerase.
Patent CA-2320918-C (CA)
Title: Anti-accretion additives for drilling fluids
Inventor: GROVER BOYD
IPC: C09K8/22
Filed: 1999-01-28
Granted: 2009-12-08
Abstract: Additives for drilling fluids, in particular for water-based drilling fluids are described which when added to the fluid at levels of up to 10 % weight by volume reduces the accretion and bit-balling tendencies of shale cuttings exposed to said fluids. The additives are based on phosphonate chemistry, and are of the general class (I), wherein R, R' and R" are radicals exclusively containing H atoms or combinations of H, C, O or P atoms up to a maximum of 100 atoms.
Patent CA-2321004-C (CA)
Title: Manual bone anchor placement devices
Inventor: GELLMAN BARRY N
IPC: A61B17/88
Filed: 1999-05-11
Granted: 2004-05-04
Abstract: Manuel bone anchor placement devices include a lever, a force translator and a rotary force mechanism. The devices are substantially gun- or pistol-shaped and are actuated when a user squeezes the lever to the gripping portion of a handle. Manual, linear force on the lever is mechanically translated through the force translator to the rotary force mechanism which transmits a rotary force to a securing element, or coupler, which mates with a bone anchor screw. The rotation of the securi ng element or coupler applies a torque on the bone anchor screw thereby placing the screw into bone. Kits comprising any of: a molded flexible sleeve for enclosing a suture, a retaining clip for preventing the suture from slipping out of the sleeve, a buttress-shaped bon e anchor screw comprising a micropolished eyelet for receiving a suture, and a suture which may, or may not be pre-attached to the bone anchor screw, are disclosed. A collapsible, protective cover for a bone anchor screw is also disclosed.
Patent CA-2328647-C (CA)
Title: Michelson phase shifter interleaver/deinterleavers
Inventor: TAI KUOCHOU
IPC: H04J14/02
Filed: 2000-12-15
Granted: 2005-06-14
Abstract: Interleavers and deinterleavers for filtering optical signals are described.  The interleaver separates subsets of channels. The deinterleavers mix subsets of channels. Interleavers and deinterleavers can be used to increase the bandwidth of an optical network. The interleavers and deinterleavers can be used to interface components designed for a first channel spacing to components designed for a second channel spacing.
Patent CA-2331258-C (CA)
Inventor: MOND JAMES J
IPC: C07K19/00
Filed: 1999-06-10
Granted: 2011-09-20
Abstract: L'invention concerne des adjuvants de vaccin comprenant la glycoprotéine 350/220 du virus d'Epstein Barr ou certaines de ses variantes naturelles, une protéine de fusion comprenant une séquence EBV Gp350/220 se fixant au récepteur CR2 ou un fragment synthétique de Gp350/220 conservant la capacité de fixation au récepteur CR2. Elle concerne, de plus, des compositions d'immunostimulation contenant une séquence d'adjuvant EBV Gp350/220 se fixant au complexe CR2 et au moins un antigène autre que Gp350/220. L'administration simultanée de cet adjuvant avec un antigène différent d'un antigène contenant la séquence EBV Gp350/220 augmente l'immunogénicité de l'antigène. Dans un mode de réalisation, cet adjuvant présente une liaison covalente directe ou indirecte avec un antigène, ce qui constitue une composition immunogène. Dans un mode de réalisation préféré de cette composition, des anticorps sont élicités contre au moins un déterminant antigénique de Gp350/220 et contre au moins un déterminant antigénique de l'antigène.
Patent CA-2332777-C (CA)
Inventor: BEYER CHRISTIAN
IPC: F04D17/16
Filed: 1998-09-11
Granted: 2007-11-06
Abstract: A friction vacuum pump (1) with a stator (3) and a rotor (4) forming at leas t two pump stages (12, 13, 14) each with one gas inlet (23, 28), in addition to connecting means for the pump stages, whereby said means are fitted with connecting openings (36, 37) and are used to connect the gas inlets of the (23, 28) of the pump stage s to devices that are to be emptied. In order to avoid high losses in conductance, the connecting openings (36, 37) are located on a single plane which is to the side of and close to the pump stages (12, 13, 14), whereby the distance between the connecting openin gs (36, 37) and the axis (15) of the rotor is as short as possible.
Patent CA-2334119-C (CA)
Title: Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase
Inventor: REED MICHAEL JOHN
IPC: A61K38/22
Filed: 1999-06-10
Granted: 2011-09-13
Abstract: A composition is described. The composition comprises i) a compound comprising a sulphamate group ("a sulphamate compound"); and ii) a biological response modifier.
Patent CA-2341227-C (CA)
Inventor: FOA MARCO
IPC: D21H19/28
Filed: 1999-08-27
Granted: 2008-11-18
Abstract: Polyester resins formed by recurring units X = [O-(CH2)n-OCO-(CH2)m-CO] and/or Y = [O-(CH2)k-CO], where the half-sum of n + m is equal to or greater than 6 and k is a number equal to or greater than 6, or by copolymers comprising units and/or sequences having the formula x i[O-(CH2)ni-OCO-(CH2)mi-CO]; y j[O-(CH2)kj-CO] where: i,j = 1-5; n i = 2-22; m i = 0-20; k j = 1=21; (Formula (1)) and x i and y j vary between 0 and 1 and are molar fractions of the various units such that (Formula (2)), are used for the preparation of products in which a permeability to water vapour of less than 350 gx30.mu.m/m2 per day, measured at 38 .degree.C and 90 % RH and good biodegradability are required.
Patent CA-2347474-C (CA)
Inventor: HILL CHRISTOPHER HUW
IPC: A61P29/00
Filed: 1999-10-13
Granted: 2008-08-26
Abstract: Les dihydropyrimido [4,5-d]pyrimidiones à substitution amino correspondant à la formule (I) et leurs sels, acceptables du point de vue pharmaceutique, sont des inhibiteurs de la protéine kinase. Dans cette formule, R<1> représente un hydrogène, un alkyle, un aryle, un arylalkyle de faible poids moléculaire, un hétéroaryle, un hétéroaryl-alkyle de faible poids moléculaire, un cycloalkyle de faible poids moléculaire ou un cycloalkyl de faible poids moléculaire alkyle de faible poids moléculaire, R<2> représente un alkyle de faible poids moléculaire, un aryle, un arylalkyle de faible poids moléculaire, un hétéroaryle, un hétéroaryl-alkyle de faible poids moléculaire, un cycloalkyle de faible poids moléculaire ou un cycloalkyle de faible poids moléculaire alkyle de faible poids moléculaire et R<3> représente un hydrogène, un alkyle de faible poids moléculaire, un aryle, un arylalkyle de faible poids moléculaire, un hétéroaryle, un hétéroaryl-alkyle de faible poids moléculaire, un cycloalkyle de faible poids moléculaire, un cycloalcényle de faible poids moléculaire ou un cycloalkyle de faible poids moléculaire alkyle de faible poids moléculaire. Il est possible d'utiliser ces substances pour le traitement ou la prévention d'états pathologiques inflammatoires, immunologiques, oncologiques, broncho-pulmonaires, dermatologiques et cardio-vasculaires ainsi que dans le traitement de l'asthme, de troubles du système nerveux central ou de complications diabétiques ou encore dans le cadre de la prévention d'un rejet de greffon à la suite d'une chirurgie de transplantation.
Patent CA-2353428-C (CA)
Inventor: TWEEDY MICHAEL J
IPC: G01P15/093
Filed: 2001-07-23
Granted: 2004-10-19
Abstract: A displacement sensor (21) and an acceleration sensor (23) are mounted to a common support member. The displacement sensor (21) comprises a first circular flexural disk (40) having a natural frequency less than the frequency range of the acoustic waves of interest. Spiral-wound optical fiber coils (53, 55) are mounted to opposite sides of the first flexural disk (40). The acceleration sensor (23) comprises a second flexural disk (68) having a natural frequency greater than the frequency range of the acoustic waves. Spiral-wound optical fiber coils (53, 55) are mounted to opposite sides of the second flexural disk (68). A fiber optic interferometer provides an output signal that is a combination of signals output from the displacement sensor (21) and the acceleration sensor (23). The displacement sensor (21) includes an inertia ring (58) mounted to an edge of the first flexural disk (40) to keep it nearly stationary when an acoustic wave in the selected frequency range is incident upon the housing (22). The flexural disks (40, 68) include upper and lower rings (72, 74) spaced apart from the support post with portions of the disks (40, 68) between the rings (72, 74) and the support post defining hinges (75) at which the flexural disks (40, 68) flex in response to acceleration of the support member along its longitudinal axis. The surfaces of the first and second flexural disks (40, 68) preferably include grooves (84) extending between the upper rings (72) and the outer edges of the flexural disks (268, 274). The grooves (84) are arranged to allow lengths of optical fiber adjacent the rings (72, 74) to pass under the optical fiber coils (77, 79) that are formed on the surfaces of the flexural disks (40, 68).
Patent CA-2353574-C (CA)
Inventor: DONG ZHENG XIN
IPC: A61P25/00
Filed: 1999-12-07
Granted: 2012-05-08
Abstract: La présente invention concerne des analogues peptidiques de peptide-1 glucanoïde, certains de leurs sels pharmaceutiquement admis, de procédés d'utilisation de tels analogues pour le traitement de mammifères, et des compositions pharmaceutiques convenant à cet effet et comprenant lesdits analogues.
Patent CA-2355771-C (CA)
Title: Medical information system, method and article of manufacture
Inventor: MAZZONE THOMAS
IPC: G06F19/00
Filed: 2001-08-17
Granted: 2010-10-12
Abstract: The invention includes a method, an article of manufacture and a system related to providing medical information and other information helpful in providing medical services.
Patent CA-2355884-C (CA)
Inventor: WILSON PHILLIP S
IPC: B29C67/00
Filed: 1999-12-17
Granted: 2009-08-25
Abstract: L'invention concerne un article moulé renforcé qui présente des protubérances renforcées prolongeant la surface de l'article, et convient pour un moulage destiné à confectionner une garniture d'automobile. L'article comprend au moins une matière thermoplastique, environ 2 à 15 % en volume de particules de renforcement en une ou plusieurs couches dont l'épaisseur des lamelles est comprise entre 0,7 et 1,2 nm. Plus de 50 % environ des particules de renforcement ont une épaisseur inférieure à environ 20 couches. Les particules de renforcement renforcent une protubérance qui prolonge la surface de l'article moulé et présente une épaisseur inférieure à 1/10 de pouce. L'invention concerne en outre un procédé de production d'articles renforcés comprenant ladite protubérance renforcée.
Patent CA-2358215-C (CA)
Title: Procede utilisant des pointes de microscope-sonde a balayage et produits convenant a ce procede ou issus de ce procede
Inventor: MIRKIN CHAD A
IPC: G03F7/00
Filed: 2000-01-07
Granted: 2012-07-31
Abstract: La présente invention concerne un microscope à force atomique (AFM) doté d'une pointe recouverte de composés hydrophobes, qui fonctionne comme une pointe de crayon pour nanolithographie (DPN), de façon à transporter des molécules de la pointe du microscope à force atomique (AFM) sur un substrat d'or (AU) afin de dessiner des motifs sur ledit substrat d'or (AU).
Patent CA-2361568-C (CA)
Title: Method and system for the discovery of cookies and other client information
Inventor: BLUMENAU TREVOR B
IPC: G06Q30/02
Filed: 2000-02-16
Granted: 2008-10-28
Abstract: A client information discovery arrangement is provided to discover client information relating to access by the clients of a plurality of web sites. Each of the clients accesses a corresponding web page stored at a central facility. The web page contains a URL for each of the web sites and an ID  uniquely identifying the corresponding client. Each client transmits, either to each of the web sites corresponding to the URLs of the web page or to the central facility, the ID  of the corresponding client and the client information which are stored by the client and which correspond to each of at least some of the URLs. The client information may include cookies.
Patent CA-2363973-C (CA)
Title: Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
Inventor: REDMOND H PAUL
IPC: A61K45/06
Filed: 2001-11-26
Granted: 2009-03-10
Abstract: Tumor growth and metastases in cancer patients are inhibited by administration of a combination therapy including effective amounts of 5-Fluorouracil and a methylol transfer agent such as taurolidine, taurultam or mixtures thereof.
Patent CA-2367613-C (CA)
Title: Dual diverter and orientation device for multilateral completions and method
Inventor: MILLIGAN CLAY W JR
IPC: E21B43/14
Filed: 2000-04-19
Granted: 2006-08-08
Abstract: The invention is a downhole well tool for use within a well casing (34') having a locking slot (40), an orienting profile (30), an alignment slot (32 ), and a lateral wellbore window (48'). The tool may include a body member (12' ) having a first (26) and a second longitudinal bore (28) extending therethrough, a diverter member (22') extending therefrom and having a diverter surface (24'). The second longitudinal bore (28) extends through th e diverter (22'). The tool may also include an outwardly-biased orienting key (14) movably secured to the body member and engageable with the orienting profile (30) and the alignment slot (32), and an outwardly-biased locking ke y (16) movably secured to the body member and engageable with the locking slot (40). The diverter surface (24') is aligned with the lateral wellbore window (48') when the orienting key (14) is engaged with the alignment slot (32) an d the locking key (16) is engaged with the locking slot (40).
Patent CA-2371010-C (CA)
Inventor: FUKASAWA KAYOKO
IPC: H04W60/04
Filed: 2002-02-06
Granted: 2010-06-22
Abstract: A switching station etc., are provided. When a mobile station moves from an area of a switching station into an area of another switching station having a VLR which has accepted the maximum number of subscribers, the switching station registers subscriber location information about the mobile station in an HLR even through it cannot register the subscriber service information in its VLR. When a call origination signal is transmitted from the mobile station, the switching station performs call origination connection processing by acquiring the subscriber service information about the mobile station from the HLR. When call termination to the mobile station occurs, the switching station can perform call termination processing normally since the subscriber location information is correctly updated in the HLR. The switching station performs call termination processing by acquiring the subscriber service information from the HLR.